Loading chat...
AR SB302
Bill
Status
5/1/2017
Primary Sponsor
Missy Irvin
Click for details
AI Summary
-
Professional licensing boards must adopt rules requiring practitioners with authority to prescribe Schedule II controlled substances to check the Prescription Drug Monitoring Program at intervals determined by the appropriate licensing board
-
Licensing boards cannot adopt rules less restrictive than those of the Arkansas State Medical Board regarding Schedule II controlled substance prescriptions
-
Licensing boards may optionally adopt rules requiring practitioners to check the program when prescribing Schedule III drugs or benzodiazepines, and may place quantity limits on any controlled substance prescriptions
-
Licensing boards may require practitioners to access the controlled substance database more frequently than minimum requirements as part of professional practice reviews
-
Practitioners who purposely fail to access the Prescription Drug Monitoring Program as required by their licensing board may be subject to disciplinary action
Legislative Description
To Amend The Prescription Drug Monitoring Program; And To Require Professional Licensing Boards To Promulgate Rules Requiring Practitioners To Access The Prescription Drug Monitoring Program.
Last Action
Sine Die adjournment
5/1/2017